Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Asthma
- Sponsor
- AstraZeneca
- Enrollment
- 40541
- Locations
- 1
- Primary Endpoint
- Asthma-related Cost
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This Retrospective cohort study with an overall objective of to perform a descriptive analysis of the asthma patient population in the Emirate of Dubai with respect to healthcare resource utilization, costs, and asthma-related treatment patterns and outcome.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Minimum two claims with asthma diagnosis, 30 days apart, during the identification period
- •Minimum 12 months of baseline period
- •Age ≥ 18 years on the index date
- •Continuous enrolment during the baseline period and at least 180 days of follow-up period; enrolment will be defined based on at least one activity during each 90-day period from the index date
Exclusion Criteria
- •Diagnosis of COPD during the baseline period. Diagnosis of COPD will be defined as ≥1 medical claim with an ICD-10 diagnosis in any position
Outcomes
Primary Outcomes
Asthma-related Cost
Time Frame: 1 Year
Total asthma-related cost reported in the databse during December 2015 through November 2018(summarized annually).It will will be computed in the follow-up period and will be reported as a percentage and number of visits per person per year (PPPY). Utilization will be considered "asthma-related" if the associated medical claim(s) has ICD-10 diagnosis code for asthma as the principal diagnosis
Asthma Patients Number
Time Frame: 1 Year
Number of unique asthma patients in the database during December 2015 through November 2018(summarized annually).it will be computed in the follow-up period and will be reported as a percentage and number of visits per person per year (PPPY). Utilization will be considered "all-cause" if the associated medical claim(s) has a diagnosis code in any position for any condition.
Secondary Outcomes
- Asthma-related hopitalizations cost(1 Year)
- Astma-related prescription pattern(1 Year)
- Severity of Asthma per total number of patients(1 Year)